Caris Life Sciences Inc. (CAI), an artificial intelligence TechBio company, Monday reported that its preliminary fourth quarter revenue and full year revenue have increased by 116 percent and 94 percent respectively, compared to the same period last year.
Following the news, CAI shares are trading up around 3.47% in the pre-market as of this writing.
Quarterly revenue increased around to $281 million and full year revenue grew to $800 million.
In pre-market activity, CAI shares were trading at $29.50, up 3.47% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.